Cargando…
Reduced HRAS(G12V)-Driven Tumorigenesis of Cell Lines Expressing KRAS(C118S)
In many different human cancers, one of the HRAS, NRAS, or KRAS genes in the RAS family of small GTPases acquires an oncogenic mutation that renders the encoded protein constitutively GTP-bound and thereby active, which is well established to promote tumorigenesis. In addition to oncogenic mutations...
Autores principales: | Huang, Lu, Counter, Christopher M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406447/ https://www.ncbi.nlm.nih.gov/pubmed/25902334 http://dx.doi.org/10.1371/journal.pone.0123918 |
Ejemplares similares
-
Decreased tumorigenesis in mice with a Kras point mutation at C118
por: Huang, Lu, et al.
Publicado: (2014) -
Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer
por: Weyandt, Jamie D., et al.
Publicado: (2015) -
Fbxw7 Deletion Accelerates Kras(G12D)-Driven Pancreatic Tumorigenesis via Yap Accumulation()()()
por: Zhang, Qiang, et al.
Publicado: (2016) -
Inactivation of Rbx1 E3 ligase suppresses Kras(G12D)
‐driven lung tumorigenesis
por: Li, Yanan, et al.
Publicado: (2023) -
Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck
por: Sasaki, Eiichi, et al.
Publicado: (2020)